<- Go Home

ImmuCell Corporation

ImmuCell Corporation, an animal health company, develops, manufactures, and sells products that enhance the health and productivity of dairy and beef cattle in the United States and internationally.

Market Cap

$28.4M

Volume

11.8K

Cash and Equivalents

$1.3M

EBITDA

-$633.7K

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

$6.6M

Profit Margin

28.32%

52 Week High

$5.64

52 Week Low

$3.34

Dividend

N/A

Price / Book Value

1.21

Price / Earnings

-6.94

Price / Tangible Book Value

1.22

Enterprise Value

$42.9M

Enterprise Value / EBITDA

-254.18

Operating Income

-$3.3M

Return on Equity

-16.10%

Return on Assets

-4.87

Cash and Short Term Investments

$1.3M

Debt

$15.8M

Equity

$23.5M

Revenue

$23.2M

Unlevered FCF

$848.4K

Sector

Biotechnology

Category

N/A

Company Stock Pitches